Clinical trial · Interventional
The Effects of Replacing Red and Processed Meat With Quorn on Biomarkers of Gut Health
The Effects of Replacing Red and Processed Meat With Quorn on Markers of Gastrointestinal Health
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will evaluate the effects of substituting red and processed meat in the diet with Quorn; a meat replacement product, on biomarkers of gut health. This will be a crossover design where participants will take part in 2 study periods where they will consume a diet containing red and processed meat during one of the study periods, whereas in the other study period, they will consume a diet containing Quorn.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Quorn | Other | — | UNRESOLVED |
| Red and Processed Meat | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Red and Processed Meat
- description
- 240 grams (raw weight) of red and processed meat every day for 2 weeks
- interventionNames
- Other: Red and Processed Meat
- type
- EXPERIMENTAL
- label
- Quorn
- description
- 240 grams (uncooked weight) of Quorn every day for 2 weeks
- interventionNames
- Other: Quorn
Primary outcomes (1)
- measure
- Genotoxic potential of Faecal extracts from volunteers consuming intervention diets rich in red and processed meat versus diets containing Quorn
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Male * 18-50 years. * Not been diagnosed with colorectal cancer, or adenomas. * Habitual omnivorous dietary pattern. * BMI ≥18-30 kg/m2. * Blood HbA1c \<58mmol/mol (\<6.5%) (not diagnosed with diabetes) * Fasting total cholesterol\<7.8 mmol/l * Triglycerides \<2.3 mmol/l * Normal liver function (assessed by measuring liver enzymes in the screening blood sample). * Blood pressure lower than BP \<140/90 mmHg. * Not suffering any cardiovascular diseases/ heart diseases e.g. stroke in the past 12 months. * Do not suffer from chronic gastrointestinal problems (e.g. Inflammatory Bowel Disease, Irritable Bowel Syndrome, coeliac disease) * Do not take supplements or medication that effects gastrointestinal health * Not participated in a pre-/probiotic or laxative trial within the previous 3 months. * Not been prescribed and/or taken antibiotics in the previous 6 months. * No history of alcohol misuse based on self-reported alcohol intake and measurement of liver enzymes in the screening blood sample. Exclusion Criteria: * Been diagnosed with colorectal cancer and/or colorectal adenomas. * Been diagnosed with gastrointestinal disorders (e.g. Inflammatory bowel disease, irritable bowel syndrome, coeliac disease) * Adherence to a dietary pattern which excludes foods from an animal origin. * Abnormal blood biochemistry based on standard clinical cut- offs, as well as blood markers not fitting the inclusion criteria set. * Have history of food intolerances/allergies (e.g. gluten or dairy) or intolerances (e.g. lactose). * Taking, or unwilling to stop taking anti-oxidant supplements (e.g. vitamin C, vitamin E, Multivitamin tablets, polyphenol supplements) * Received antibiotics in the previous 6 months. * Have participated in similar dietary or prebiotic/probiotics study in the previous 3 months. * Current smoker.
References
Publications (2)
- DERIVEDFarsi DN, Gallegos JL, Finnigan TJA, Cheung W, Munoz JM, Commane DM. The effects of substituting red and processed meat for mycoprotein on biomarkers of cardiovascular risk in healthy volunteers: an analysis of secondary endpoints from Mycomeat. Eur J Nutr. 2023 Dec;62(8):3349-3359. doi: 10.1007/s00394-023-03238-1. Epub 2023 Aug 25. PMID 37624376
- DERIVEDFarsi DN, Gallegos JL, Koutsidis G, Nelson A, Finnigan TJA, Cheung W, Munoz-Munoz JL, Commane DM. Substituting meat for mycoprotein reduces genotoxicity and increases the abundance of beneficial microbes in the gut: Mycomeat, a randomised crossover control trial. Eur J Nutr. 2023 Apr;62(3):1479-1492. doi: 10.1007/s00394-023-03088-x. Epub 2023 Jan 18. PMID 36651990